Cargando…

Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone and renin levels in diabetes mellitus type 2 patients: a systematic review and meta-analysis

The effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on plasma aldosterone concentration (PAC) and plasma renin activity (PRA) levels are still inconclusive. This meta-analysis aimed to demonstrate the changes in PAC and PRA levels after the use of SGLT2i in type 2 diabetes patients. A s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manosroi, Worapaka, Danpanichkul, Pojsakorn, Atthakomol, Pichitchai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666660/ https://www.ncbi.nlm.nih.gov/pubmed/36380013 http://dx.doi.org/10.1038/s41598-022-24280-9

Ejemplares similares

Hormone replacement therapy in women and risk of carpal tunnel syndrome: a systematic review and metaanalysis
por: Manosroi, Worapaka, et al.
Publicado: (2023)

Predictive model for prolonged length of hospital stay in patients with osteoporotic femoral neck fracture: A 5-year retrospective study
por: Manosroi, Worapaka, et al.
Publicado: (2023)

High body fat percentage is associated with primary aldosteronism: a cross-sectional study
por: Manosroi, Worapaka, et al.
Publicado: (2020)

Clinical and biochemical predictors and predictive model of primary aldosteronism
por: Manosroi, Worapaka, et al.
Publicado: (2022)

Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis
por: Manosroi, Worapaka, et al.
Publicado: (2022)

Predictive factors of clinical success after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis
por: Manosroi, Worapaka, et al.
Publicado: (2022)

The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review
por: Manosroi, Worapaka, et al.
Publicado: (2022)

Is Preoperative Adrenal Insufficiency Screening Necessary for Cardiovascular Thoracic Surgery Patients?
por: Manosroi, Worapaka, et al.
Publicado: (2023)

Clinical and biochemical factors to predict biochemical adrenal insufficiency in hospitalized patients with indeterminate cortisol levels: a retrospective study
por: Manosroi, Worapaka, et al.
Publicado: (2020)

Diagnostic performance of basal cortisol level at 0900-1300h in adrenal insufficiency
por: Manosroi, Worapaka, et al.
Publicado: (2019)

Predictive Factors of Adrenal Insufficiency in Outpatients with Indeterminate Serum Cortisol Levels: A Retrospective Study
por: Manosroi, Worapaka, et al.
Publicado: (2020)

Preoperative Correction of Low Hemoglobin Levels Can Reduce 1-Year All-Cause Mortality in Osteoporotic Hip Fracture Patients: A Retrospective Observational Study
por: Manosroi, Worapaka, et al.
Publicado: (2022)

A Predictive Risk Score to Diagnose Adrenal Insufficiency in Outpatients: A 7 Year Retrospective Cohort Study
por: Manosroi, Worapaka, et al.
Publicado: (2021)

Comparison of single-dose radial extracorporeal shock wave and local corticosteroid injection for treatment of carpal tunnel syndrome including mid-term efficacy: a prospective randomized controlled trial
por: Atthakomol, Pichitchai, et al.
Publicado: (2018)

Prognostic Factors for All-Cause Mortality in Thai Patients with Fragility Fracture of Hip: Comorbidities and Laboratory Evaluations
por: Atthakomol, Pichitchai, et al.
Publicado: (2020)

Short incision versus minimally invasive surgery with tool-kit for carpal tunnel syndrome release: a prospective randomized control trial to evaluate the anterior wrist pain and time to return to work or activities
por: Atthakomol, Pichitchai, et al.
Publicado: (2022)

Comparison of patient preferences and responsiveness among common patient-reported outcome measures for hand/wrist injuries or disorders
por: Chanthana, Phongniwath, et al.
Publicado: (2023)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
por: Sawamura, Toshitaka, et al.
Publicado: (2020)

A Thai version of the Michigan hand questionnaire (Thai MHQ): an investigation of the psychometric properties
por: Atthakomol, Pichitchai, et al.
Publicado: (2020)

Field testing and psychometric properties of Thai version of the Boston carpal tunnel questionnaire
por: Atthakomol, Pichitchai, et al.
Publicado: (2023)

Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
por: Ansary, Tuba M., et al.
Publicado: (2019)

Effects of Sodium Glucose Cotransporter 2 Inhibitor on Renal Renin-Angiotensin-Aldsoterone System
por: Takeda, Yoshiyu, et al.
Publicado: (2021)

Modulation of the cardiac sodium/bicarbonate cotransporter by the renin angiotensin aldosterone system: pathophysiological consequences
por: De Giusti, Verónica C., et al.
Publicado: (2014)

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
por: Ahmadieh, Hala, et al.
Publicado: (2017)

The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019
por: Danpanichkul, Pojsakorn, et al.
Publicado: (2023)

Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease
por: Rikin, Sharon, et al.
Publicado: (2022)

Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus
por: Vinke, Joanna Sophia J., et al.
Publicado: (2019)

The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
por: Xu, Bo, et al.
Publicado: (2022)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
por: Cavaiola, Tricia Santos, et al.
Publicado: (2018)

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
por: Sano, Motoaki
Publicado: (2017)

Renal outcomes with sodium-glucose cotransporters 2 inhibitors
por: Sun, Xiaoya, et al.
Publicado: (2022)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
por: Tang, Jun, et al.
Publicado: (2022)

Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
por: Cao, Yang, et al.
Publicado: (2022)

Improvement in Serum Magnesium Levels With Sodium-Glucose Cotransporter 2 Inhibitors
por: Saha, Arunava, et al.
Publicado: (2022)

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
por: Fioretto, Paola, et al.
Publicado: (2015)

Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
por: Pradhan, Akshyaya, et al.
Publicado: (2019)

A New Hope in Type 2 Diabetes Mellitus Management: Sodium-Glucose Cotransporter 2 Inhibitors
por: Chaurasia, Pallavi Prakash, et al.
Publicado: (2021)

The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
por: Dong, Meiyuan, et al.
Publicado: (2023)

Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2018)

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure
por: Reed, James W
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1m3kpbk8no1p31uf2ig59n8gkb